The MMAA gene helps your cells use vitamin B12 to support an enzyme that breaks down certain fats and proteins for energy. If the MMAA gene does not work properly, methylmalonic acid can build up in the body and cause a condition called methylmalonic acidemia. This often leads to poor feeding, vomiting, low energy, and delayed development, sometimes starting in infancy. In some people, symptoms appear later, and some cases improve with vitamin B12 treatment.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Others mostly help direct when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
MMAAGene function
What if the gene works
The MMAA gene helps cells use vitamin B12 inside mitochondria, the parts of cells that make energy. This supports an enzyme that breaks down certain fats and proteins and helps keep methylmalonic acid levels in balance.
Risk
What if the gene does not work
Variants in the MMAA gene can cause cblA-type methylmalonic acidemia, making it harder to process parts of protein and fat. This may cause poor feeding, vomiting, low energy, and developmental delay. Milder or more severe variants can change onset and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the MMAA gene often indicate a form of methylmalonic acidemia that can respond to hydroxocobalamin, a prescription form of vitamin B12, so this medicine is a key treatment choice. Many people with MMAA-related disease show lower methylmalonic acid levels and clinical improvement with regular hydroxocobalamin alongside standard metabolic care.
Conditions associated with MMAA
Gene function
What if the gene works
Inside your cells, the MMAA gene helps manage a specialized form of vitamin B12 in mitochondria, the parts of cells that help make energy. This support keeps an important metabolic enzyme supplied and working in a controlled way. In everyday terms, what the MMAA gene does is help cells process certain fats and proteins as part of normal energy use.
The MMAA gene helps your cells handle a working form of vitamin B12 inside mitochondria. This form is needed for a key step in normal metabolism.
Its protein works with methylmalonyl-CoA mutase, an enzyme that helps break down certain parts of fats and proteins. It helps the enzyme receive the vitamin B12 helper it needs for steady activity.
The MMAA protein helps manage the enzyme’s vitamin B12 helper in a controlled way. This supports smooth day to day energy metabolism in your cells.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human variation, including traits such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic diversity. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MMAA gene can weaken this mitochondrial helper protein by making it unstable, shortening it, or disrupting how it handles vitamin B12 and interacts with methylmalonyl CoA mutase. These MMAA gene variants may leave some activity intact or nearly eliminate it, so their effects can range from milder to more severe. When function is more reduced, the cblA form of methylmalonic acidemia often appears earlier or with more marked features.
How variants are linked to conditions
Pathogenic variants in the MMAA gene cause methylmalonic acidemia, cblA type, an inherited condition that can lead to poor feeding, vomiting, low energy, delayed development, and episodes of metabolic illness, often starting in infancy or childhood. The main established MMAA gene methylmalonic acidemia association is this cblA form. Severity can vary from person to person, even within the same family.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MMAA, risk is mainly set by inheritance: the condition usually happens when a child receives two changed copies of the gene, so family history and both parents being carriers raise the chance. In people living with MMAA-related methylmalonic acidemia, infections, long fasting, and poor food intake can increase the risk of a metabolic crisis.
Inheritance of MMAA variants
Variants in the MMAA gene linked to MMAA-related methylmalonic acidemia are inherited in an autosomal recessive pattern. This means a child usually inherits one changed copy from each parent. Parents who each carry one MMAA gene variant are typically unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. Sons and daughters are affected at the same rate.
What does my MMAA result mean for my family?
Changes in the MMAA gene are linked to a condition that usually runs in families in a recessive pattern. For relatives, this mainly means that parents are often healthy carriers, and brothers or sisters may also be affected or be carriers even if they feel well. Other close family members may also carry the changed gene, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the MMAA gene usually uses a blood or saliva sample. The lab reads your DNA to look for changes in the MMAA gene, either on its own or on a panel for methylmalonic acidemia, and the results can show whether you carry two pathogenic variants, one variant, or none that explain the condition.
When should I consider getting a genetic test?
Testing may be worth considering if you or your child has signs of methylmalonic acidemia, a condition where certain acids build up in the body, or if a newborn screen or family history points to it. Finding a harmful MMAA change can confirm the diagnosis and help guide care.
A genetic result is only one part of your health story
Genetic results can provide useful insight, although what they can tell you varies depending on the condition and the kind of variant involved. Over time, many other factors also affect how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as response to medication, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it at different speeds, which can change how well it works or how likely side effects are. These differences are common and can influence how strongly the body responds, how long a medicine stays in the body, and how sensitive someone may be to treatment.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strong a drug’s effect is or how the body handles it. This information can support more informed and more personalized treatment decisions. To learn more about this topic, you can visit the LearnHub.
Drugs influenced by the MMAA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine response, so questions about symptoms, treatment, new side effects, or possible drug interactions are best discussed with your doctor.
History
MMAA entered the medical literature through research on methylmalonic acidemia, a rare inherited condition recognized long before the gene itself was identified. Initially, doctors classified affected families by biochemical patterns and by complementation groups, a way of sorting cases that seemed similar but had different genetic causes. Building on this early work, scientists linked one of these groups, known as cblA, to variants in the MMAA gene in the early 2000s. That discovery helped connect older clinical observations with a specific genetic explanation. Over time, descriptions became more precise as genetic testing replaced earlier, more indirect methods. These steps shaped today’s understanding of MMAA in inherited metabolic medicine.